Detection of neutralizing antibodies in postweaning multisystemic wasting syndrome (PMWS)-affected and non-PMWS-affected pigs.
about
Immunity Elicited by an Experimental Vaccine Based on Recombinant Flagellin-Porcine Circovirus Type 2 Cap Fusion Protein in PigletsModelling the time-dependent transmission rate for porcine circovirus type 2 (PCV2) in pigs using data from serial transmission experiments.Dynamics of serum antibodies to and load of porcine circovirus type 2 (PCV2) in pigs in three finishing herds, affected or not by postweaning multisystemic wasting syndromeReduction of porcine circovirus type 2 (PCV2) viremia by a reformulated inactivated chimeric PCV1-2 vaccine-induced humoral and cellular immunity after experimental PCV2 challenge.Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodiesVirus-like particles of chimeric recombinant porcine circovirus type 2 as antigen vehicle carrying foreign epitopes.Antibody recognition of porcine circovirus type 2 capsid protein epitopes after vaccination, infection, and disease.Co-expression of ubiquitin gene and capsid protein gene enhances the potency of DNA immunization of PCV2 in micePCV2 vaccination induces IFN-γ/TNF-α co-producing T cells with a potential role in protection.T-cell reprogramming through targeted CD4-coreceptor and T-cell receptor expression on maturing thymocytes by latent Circoviridae family member porcine circovirus type 2 cell infections in the thymus.Variation in time and magnitude of immune response and viremia in experimental challenges with Porcine circovirus 2b.Fetal infections and antibody profiles in pigs naturally infected with porcine circovirus type 2 (PCV2)Genetic characterization of porcine circovirus type 2 from pigs with porcine circovirus associated diseases in Argentina.Effect of sow vaccination against porcine circovirus type 2 (PCV2) on virological profiles in herds with or without PCV2 systemic diseaseThe index herd with PMWS in Sweden: presence of serum amyloid A, circovirus 2 viral load and antibody levels in healthy and PMWS-affected pigs.Evaluation of natural porcine circovirus type 2 (PCV2) subclinical infection and seroconversion dynamics in piglets vaccinated at different ages.Effect of porcine circovirus type 2 (PCV2) vaccination on PCV2-viremic piglets after experimental PCV2 challenge.Best practice and future challenges for vaccination against porcine circovirus type 2.Time course differential gene expression in response to porcine circovirus type 2 subclinical infection.Pigs naturally exposed to porcine circovirus type 2 (PCV2) generate antibody responses capable to neutralise PCV2 isolates of different genotypes and geographic origins.Nanoparticle orientationally displayed antigen epitopes improve neutralizing antibody level in a model of porcine circovirus type 2.Suppressor of cytokine signaling 3 plays an important role in porcine circovirus type 2 subclinical infection by downregulating proinflammatory responses.Capsid proteins from PCV2a genotype confer greater protection against a PCV2b strain than those from PCV2b genotype in pigs: evidence for PCV2b strains becoming more predominant than PCV2a strains from 2000 to 2010s.Oral application of freeze-dried yeast particles expressing the PCV2b Cap protein on their surface induce protection to subsequent PCV2b challenge in vivo.Diagnosis of porcine circovirus type 2 infection with a combination of immunomagnetic beads, single-domain antibody, and fluorescent quantum dot probes.Exploitation of stable nanostructures based on the mouse polyomavirus for development of a recombinant vaccine against porcine circovirus 2.Genomic analysis of the differential response to experimental infection with porcine circovirus 2b.Porcine circovirus type 2 (PCV2)-infection and re-inoculation with homologous or heterologous strains: virological, serological, pathological and clinical effects in growing pigs.Experimental co-infection of pigs with Bovine viral diarrhea virus 1 and Porcine circovirus-2.High-level expression and immunogenicity of a porcine circovirus type 2 capsid protein through codon optimization in Pichia pastoris.Theoretical and experimental approaches to estimate the usefulness of pooled serum samples for the diagnosis of postweaning multisystemic wasting syndrome.Neutralizing antibodies against porcine circovirus type 2 in liquid pooled plasma contribute to the biosafety of commercially manufactured spray-dried porcine plasma.Development of porcine circovirus 2 (PCV2) open reading frame 2 DNA vaccine with different adjuvants and comparison with commercial PCV2 subunit vaccine in an experimental challenge.Porcine circovirus 2 immunology and viral evolution.A two-year follow-up study of the PCV2 status of a Danish pig herd that was initially assumed to be PCV2-free.Detection of PCV2e strains in Southeast China.Antibody response between pigs of Piau and a commercial breed naturally infected with Porcine circovirus 2Porcine circovirus 2 (PCV-2) genetic variability under natural infection scenario reveals a complex network of viral quasispecies
P2860
Q27326717-0F77064A-FCCF-4231-92C7-AA65D2BED763Q31159468-3379C557-315A-47E5-9E99-6AD267E6058CQ33780340-1C4FE54E-DFD4-40B3-B381-AA3D71AF6C86Q34451426-4C565803-B50E-4E89-BB31-883937C74183Q34695066-381421AC-05BF-4F13-BF07-035246269AADQ34774771-A6D539FD-736B-41C9-8DA0-6B62DFE519F4Q35066205-1874B8CA-12DA-4A54-9316-B30D1A0D2E3FQ35102883-7582DF22-B70B-4DC0-8B1D-4DCCB5F2FC81Q35142582-A3703C92-562C-4F40-8977-031EB5D1F5D0Q35164842-C36696F9-12C8-4631-AD57-40C17FCCFAF0Q35487036-330909DC-4C67-44BB-B5D5-D40864671EF8Q35628356-538EE970-EB2B-4473-B953-513CA07AC048Q36857578-B91DFCC6-3344-47EE-BD06-1D730CD2885CQ36900388-445ABEDE-BCE4-4D91-B4CC-B83C39D81748Q37185952-21A13FD7-E895-42DD-93F5-7624A3CA4AA9Q37470430-AB574897-212C-421E-AB5D-C9C4EF0AC169Q37581980-263E549E-C27D-4F74-BF98-242BADF5BBD5Q38268599-C834316A-2D42-4D9A-B718-A5A739EF16E7Q38508707-7271408C-6845-4D13-98AC-973ACDD14F71Q38903870-CBB58A3D-8430-4DE8-99B6-F48883EF17A3Q40109161-2AB57209-7F3F-4858-B488-F306A72DCD33Q40556038-D9AAED55-0DE8-4246-83E0-921EEB74A83AQ40738731-3F0C1ADD-4C80-48EE-9B60-C6E7C9C6303EQ40947516-4769E5E4-C112-4C8B-975D-1212E22C92BEQ41118801-CC13914A-F7D1-4275-A0C7-7D284E201DCFQ41702578-930CFEDD-19A8-4B1D-BCF2-82C1BAA65592Q42242311-6D538F17-57E9-4F56-BD34-55273A229041Q42910025-80B19085-6F13-40B9-B97C-A01EE6867C42Q42977970-04ECE015-2D34-4446-B6F1-9C5D530B18F3Q43741583-B9AC5C3F-B740-4A27-8B87-9401C6EA2A43Q45124023-0ED6326E-FE09-4CA7-BB68-94B01743FBAFQ45719524-1FE3A432-8C8B-477D-AC8B-DD26BB776179Q47102234-644BBD48-924E-4AD6-A447-CDD824BCBCDCQ50938133-9D8373C9-7A71-4E26-AF4A-EB7847674003Q51007201-5D7BA9A5-539C-4EBE-8862-8FCCA9FD4D8EQ52614412-3A249325-CB95-4C42-B3FA-0C1F56D2DD16Q57757381-E03F264C-6189-41E5-A5BE-F1F24CDE4275Q57811578-2D053B04-D320-4A61-9703-10E46A230653
P2860
Detection of neutralizing antibodies in postweaning multisystemic wasting syndrome (PMWS)-affected and non-PMWS-affected pigs.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Detection of neutralizing anti ...... ed and non-PMWS-affected pigs.
@en
Detection of neutralizing antibodies in postweaning multisystemic wasting syndrome
@nl
type
label
Detection of neutralizing anti ...... ed and non-PMWS-affected pigs.
@en
Detection of neutralizing antibodies in postweaning multisystemic wasting syndrome
@nl
prefLabel
Detection of neutralizing anti ...... ed and non-PMWS-affected pigs.
@en
Detection of neutralizing antibodies in postweaning multisystemic wasting syndrome
@nl
P50
P1476
Detection of neutralizing anti ...... ed and non-PMWS-affected pigs.
@en
P2093
Alex Olvera
Maria Fort
P304
P356
10.1016/J.VETMIC.2007.06.004
P577
2007-06-13T00:00:00Z